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Abstract
Background: Spx, an ArsC (arsenate reductase) family member, is a global transcriptional regulator of the microbial stress
response and is highly conserved amongst Gram-positive bacteria. Bacillus subtilis Spx protein exerts positive and negative
control of transcription through its interaction with the C-terminal domain of the RNA polymerase (RNAP) a subunit (aCTD).
Spx activates trxA (thioredoxin) and trxB (thioredoxin reductase) in response to thiol stress, and bears an N-terminal
C10XXC13 redox disulfide center that is oxidized in active Spx.
Methodology/Principal Findings: The structure of mutant Spx
C10S showed a change in the conformation of helix a4. Amino
acid substitutions R60E and K62E within and adjacent to helix a4 conferred defects in Spx-activated transcription but not
Spx-dependent repression. Electrophoretic mobility-shift assays showed aCTD interaction with trxB promoter DNA, but
addition of Spx generated a supershifted complex that was disrupted in the presence of reductant (DTT). Interaction of
aCTD/Spx complex with promoter DNA required the cis-acting elements -45AGCA-42 and -34AGCG-31 of the trxB promoter.
The Spx
G52R mutant, defective in aCTD binding, did not interact with the aCTD-trxB complex. Spx
R60E not only failed to
complex with aCTD-trxB, but also disrupted aCTD-trxB DNA interaction.
Conclusions/Significance: The results show that Spx and aCTD form a complex that recognizes the promoter DNA of an
Spx-controlled gene. A conformational change during oxidation of Spx to the disulfide form likely alters the structure of Spx
a helix a4, which contains residues that function in transcriptional activation and aCTD/Spx-promoter interaction. The
results suggest that one of these residues, R60 of the a4 region of oxidized Spx, functions in aCTD/Spx-promoter contact
but not in aCTD interaction.
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Introduction
Spx is a member of the ArsC (arsenate reductase) family of
proteins and is a unique transcriptional regulator of Gram-positive
bacteria [1]. In Bacillus subtilis, its primary function is in the global
control of the thiol stress response [2]. A role for Spx in pathogenesis
has been inferred from studies of Staphylococcus aureus, Listeria
monocytogenes, Bacillus anthracis,a n dStreptococcus mutans, in which it is
produced upon host cell infection and serves to control the
expression of virulence determinants [3,4,5,6,7]. B. subtilis Spx
interacts with the C-terminal domain of the a subunit (aCTD) of
RNA polymerase (RNAP), and in doing so, exerts both positive and
negativecontrolofgenetranscription[2,8].Geneticandbiochemical
studies showed that the G52 residue of Spx and the Y263 residue of
aCTD form part of the contact interface between Spx and RNAP,
which was confirmed by the x-ray structure determination of the
aCTD/Spx complex [9]. The Y263 is conserved in Gram-positive
bacteria and is not found in the Gram-negatives [1].
In vitro transcription experiments showed that Spx directly
activates transcription of genes involved in thiol homeostasis,
including trxA (thioredoxin gene) and trxB (thioredoxin reductase)
[10,11]. Spx-dependent transcriptional activation is under redox
control, requiring a CXXC disulfide center at the protein’s N-
terminus [10]. The oxidized form of Spx activates transcription of
genes under its control.
Upon oxidative stress, Spx concentrations increase due to
enhanced transcription and decreased proteolysis. Increased spx
transcription is attributed, in part, to inactivation of the PerR and
YodR repressors that negatively control spx transcription during
non-stress conditions [12,13]. Spx is also under proteolytic control
requiringtheATP-dependentClpXPprotease[8,14],butSpxisable
to escape from the proteolysis under oxidative conditions because
both the ClpX ATPase subunit and YjbH, an Spx-specific adaptor
protein involved in ClpXP proteolysis of Spx, are inactivated by
oxidants [15,16,17]. YjbH, a Zn-binding protein, interacts with Spx
and the interaction accelerates the proteolysis of Spx by ClpXP [15].
Oxidative stress releases Zn from YjbH and ClpX, which is thought
to result in loss of YjbH-mediated proteolysis.
The tight transcriptional and post-translational control of
intracellular Spx is logical from a physiological viewpoint, given
that the Spx-dependent regulation is exerted over a genome-wide
scale. When Spx levels increase, as a result of either a null
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transcription of a large set of genes is reduced [2,8]. Most, if not
all, of these genes are positively controlled by transcription
activators. For example, ComA-dependent srfA transcription is
repressed when Spx is overproduced. ComA binds to the
regulatory region of srfA and recruits RNAP to the promoter
region through the interaction of ComA and aCTD [18,19,20].
ComA-dependent srfA transcription requires residues C265 and
K267 located in the a1 helix of aCTD [20]. Y263, the residue of
aCTD that interacts with Spx, is also located in the a1 helix,
indicating that Spx likely competes for binding of aCTD with
ComA [9,20]. The adverse effect of Spx on ResD-dependent
transcription of fnr was explained by a similar interference of
ResD-aCTD interaction by Spx [21].
The interference model of activator-aCTD complex disruption
by Spx is consistent with the observation that free Spx does not
bind to DNA [10]. Furthermore, the DNA sequence-independent
mechanism of action can explain why Spx adversely affects
transcription of a wide range of genes. On the other hand, it
remains unresolved whether Spx-dependent transcriptional acti-
vation involves binding of Spx to a specific sequence within target
promoter DNA. A previous study showed that oxidized Spx alone
does not bind to the trxA or trxB promoters [10], although this does
not necessarily eliminate the possibility that Spx, when complexed
with RNAP, directly binds to a sequence within an Spx-activated
promoter. In fact, previous DNase I footprinting analyses showed
that neither RNAP nor Spx individually binds to trxA and trxB,
while the presence of both RNAP and Spx resulted in footprints
covering a region between 250 and 210 within each promoter
[10]. This result indicates that Spx, after forming a complex with
aCTD, directs RNAP to Spx-activated promoters, either by
altering the way in which RNAP engages the promoter, or by
forming part of the binding surface which specifically recognizes
Spx-activated promoter sequences. In the hope of obtaining direct
evidence of a DNA-protein interaction in the transcription
initiation complex at the trxA and trxB promoters, we carried out
site-specific DNA and protein crosslinking using trxA (and trxB)
promoter DNA, RNAP, and Spx [11]. Contact of Spx with
promoter DNA was not detected by crosslinking at any of the
nucleotide positions examined. The addition of Spx resulted in
enhanced s
A contact with the 210 region of the trxA and trxB
promoter at 37uC. Similarly, Spx stimulated contact of the bb’
subunits of RNAP with nucleotide base positions near the
transcription start sites and around 221/222 in both promoters.
That study also uncovered evidence of a cis-acting element
upstream of the core promoter sequences in Spx-controlled genes
that is required for Spx-activated transcription [11].
In this work, we identify the cis-sequence in the trxB promoter
that is essential for Spx-dependent transcriptional activation. As
previously shown, Spx alone is unable to bind the trxB promoter,
but Spx is capable of generating a supershifted trxB-aCTD-Spx
complex in an electrophoretic mobility shift assay (EMSA). In
parallel, structural studies identify a change in the conformation of
a helix a4 of Spx when residue C10 of the redox disulfide center at
its N-terminus is mutated to serine. When R60, a residue
associated with the helix a4 region, is mutated to glutamate,
Spx-dependent transcription of trxB in vivo and binding of the
aCTD-Spx complex to the trxB promoter in vitro are abolished.
Materials and Methods
Crystallization and Structural Analysis of Reduced Spx
‘‘Reduced’’ Spx, in which residue Cys10 was replaced by serine
(C10S Spx), was overexpressed in E. coli and purified by Ni
2+-NTA
affinity column chromatography as previously described [9].
Purified, cleaved Spx was dialyzed into 25 mM PIPES, pH 6.5,
100 mM KCl for use in subsequent crystallization trials.
aCTD containing residues 245 to 314 of RpoA was cloned into
the IPTG-inducible PET28a overexpression vector (Invitrogen),
which contains an N-terminal histidine tag and thrombin cleavage
site. The aCTD-PET28a vector was transformed into Rosetta 2
competent cells (EMD Biosciences) for overexpression. aCTD was
purified by Ni-NTA affinity chromatography (Qiagen). Following
purification, the histidine tag was cleaved by incubation with
thrombin protease (GE Healthsciences). Purified, cleaved aCTD
was dialyzed into 25 mM Pipes, pH 6.5, 100 mM KCl. The Spx-
aCTD complex was formed by mixing equimolar amounts of
purified C10S Spx and aCTD. The complex was concentrated to
10 mg/ml.
Crystals of the reduced C10S Spx-aCTD complex were grown
by the hanging-drop vapor diffusion method. Two microliters of
0.5 mM C10S Spx-aCTD was mixed with 2 mL of reservoir
solution containing 25%–30% polyethylene glycol 4000, 0.1 M
sodium citrate pH 5.3 and 0.1 M MgCl2. Crystals appeared
within two to three days and reached maximum dimensions of
0.360.0560.05 mm
3 in approximately one week. The crystals
were cryoprotected in the mother liquor plus the addition of 15%
glycerol and flash frozen in a nitrogen stream at 2180uC. X-ray
intensity data were collected on beamline 8.3.1 at the Advanced
Light Source and data were processed using MOSFLM [22] as
implemented in the CCP4 suite of programs (CCP4, 2004)
(Table 1). The crystals took the spacegroup P1 with cell
dimensions a=29.4 A ˚, b=32.2 A ˚, c=50.6 A ˚, a=106.1u,
b=91.6u, c=103.8u.
The structure of the C10S Spx-aCTD complex was solved by
molecular replacement using the oxidized Spx-aCTD structure as
the search model (Table 1). Manual fitting and adjustment of the
Table 1. Selected Crystallographic Data and Statistics.
SpxC10S-aCTD
Data Collection
Wavelength (A ˚) 1.0000
Resolution (A ˚) 48.3–1.9
No. Observed Reflections 174,032
No. Unique Reflections 12,912
Completeness (%) (last shell) 95.1 (94.9)
I/sI (last shell) 7.7 (2.9)
Rsym (%)
a (last shell) 5.9 (23.0)
Refinement
Resolution (A ˚) 48.3–1.9
Reflections (working set/test set) 12,250/662
Protein Atoms (#) 1,465
Solvent Molecules (#)4 0
Rwork/Rfree (%)
b 23.6/27.8
RMSD bond lengths (A ˚) 0.006
RMSD bond angles (u) 1.27
Average B-factor (A ˚2) 38.5
aRsym=gg|Ihkl-Ihkl(j)|/gIhkl, where Ihkl(j) is the observed intensity and Ihkl is
the final average value of intensity.
bRwork=g||Fobs|2|Fcalc||/g|Fobs|a n dR free=g||Fobs|2|Fcalc||/g|Fobs|; where all
reflections belong to a test set of 5% randomly selected data.
doi:10.1371/journal.pone.0008664.t001
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Spx and residues 245–311 of aCTD into the electron density map
using O [23]. The initial protein model was subjected to rigid body
refinement, followed by simulated annealing and positional and B-
factor refinement using CNS [24]. Simulated-annealing omit maps
were calculated to ensure the correct placement of all residues and
to avoid model bias. The final model included residues 1–115 of
Spx, residues 245–311 of aCTD, and 40 solvent molecules. The
final Rwork and Rfree are 23.6% and 27.8%, respectively, to 1.9 A ˚
resolution. The stereochemistry of the final model was assessed
with PROCHECK [25], which revealed 89.7% of all w/y angles
in the most favored regions of the Ramachandran plot and none in
the disallowed regions. The coordinates and structure factors have
been deposited in the RCSB with accession number 3IHQ.
Construction of Spx Amino Acid Substitution Mutants
All bacterial strains and plasmids are listed in Table 2. The
effect of Spx amino acid substitution was examined with the Spx
construct carrying amino acid substitutions (AN to DD) at the
carboxyl-terminal end, which renders Spx insensitive to ClpXP
proteolysis [2]. The previously constructed plasmids pSN56 [2]
and pZY14 [20] are pDR111 derivatives that carry spx
DD and
spx
C10A-DD, respectively. pDR111 is an amyE integration vector,
and the cloned spx genes are transcribed from the IPTG-inducible
Pspankhy promoter [26].
Three additional spx mutations conferring single amino acid
substitutions were generated by two-step PCR-based mutagenesis
using a pair of complementary mutagenic oligonucleotides 2
oMMN07-351 and oMMN07-352 for R60E, oMMN07-353 and
oMMN07-354 for K62E, and oMMN07-355 and oMMN07-356
for K66E. Each oligonucleotide pair was used for the first PCR,
together with either the upstream oligonucleotide oMMN01-173
or the downstream oligonucleotide oMMN01-174 and the plasmid
pSN56 as template. The two PCR products carrying short
complementary ends were annealed, filled-in by ExTaq polymer-
ase (Takara Bio USA), and used as template for the second-round
of PCR using oMMN01-173 and oMMN01-174. The PCR
product was digested with SalI and HindIII and cloned into
pDR111 and digested with the same enzymes to generate
pMMN683 (spx
DD-R60E), pMMN684 (spx
DD-K62E), and pMMN685
(spx
DD-K66E).
Plasmid pMMN754 carrying spx
DD-G52R was generated as
follows. The spx gene carrying the G52R mutation was amplified
from chromosomal DNA isolated from ORB4055 using oligonu-
cleotides oMMN01-173 and oMMN01-174. The PCR product
was digested with HindIII and BclI and the 59-end of spx
containing the G52R mutation was isolated. The 39-end of spx
carrying the DD mutation was isolated from pSN56 digested with
BclI and SalI. The two fragments were cloned into pUC19
digested with HindIII and SalI by three-fragment ligation to
generate pMMN753. The spx fragment was isolated from
pMMN753 digested with HindIII and SalI and cloned into the
HindIII-SalI sites of pDR111 to generate pMMN754.
The effect of the R60E, K62E, and K66E mutations of Spx on
trxB expression was determined by measuring lacZ expression
driven by the trxB promoter (2510 to +190 relative to the
transcription start site) as previously described [10]. Plasmids
pMMN683 (spx
DD-R60E), pMMN684 (spx
DD-K62E), and pMMN685
(spx
DD-K66E) were used to transform ORB4566 carrying spx::neo and
trxB-lacZ at thrC, and transformants were selected for spectinomy-
cin resistance (Spc
r) to generate ORB6895, ORB6896, and
ORB6897, respectively. The transformants were screened for
the amylase-negative phenotype, which is indicative of double-
crossover recombination [27]. As a control, pSN56 carrying the
wild-type Spx
DD was used to transform ORB4566, and ORB6894
was obtained.
The strains carrying srfA-lacZ and the wild-type or mutant
Spx
DD were constructed as follows. The strain JH642 was
transformed with pMMN683, pMMN684, and pMMN685, and
the strains ORB6930, ORB6931 and ORB6932 were constructed
as described above. Each strain was transduced with SPb phage
carrying pMMN92-borne srfA-lacZ [18] to generate ORB6934,
ORB6935, and ORB6936. A control strain, ORB6129, carrying
the wild-type Spx
DD at the thrC locus and the srfA-lacZ fusion was
constructed as previously described [20].
Construction of trxB Promoter Mutations
All mutant trxB promoters are derivatives of pDYR9 [11], which
carries the trxB promoter (2115 to +47) fused to lacZ. Base
substitution mutations of the trxB promoter were constructed by
two-step PCR using complementary mutagenic primer pairs in a
procedure similar to that used for the amino acid substitutions of
Spx. The sequences of mutagenic oligonucleotides are listed in
Table 3, and the outside forward (oDYR07-52) and reverse
primers (oDYR07-32) were previously described [11]. DNA
fragments resulting from the second PCR were digested with
EcoRI and HindIII and cloned into pDG793 [28] that had been
digested with the same enzymes. pDG793 is a thrC integration
plasmid and double-crossover recombination is selected by Thr
-
phenotype. Each plasmid was used to transform ORB3834
(spx::neo), and erythromycin-resistant (Erm
r) Thr
- transformants
were then transformed with chromosomal DNA isolated from
strains carrying the wild-type and mutant spx
DD at the amyE locus.
All plasmids are listed in Table 2.
Measurement of b-galactosidase Activity
The effect of the Spx amino acid substitutions on the expression
of trxB and srfA was determined by measuring b-galactosidase
activity in cells carrying trxB-lacZ (ORB6894 to ORB6897) and
srfA-lacZ (ORB6129, ORB6930 to ORB6932) in the presence and
absence of IPTG. The strains were grown at 37uC overnight on
DS agar plates [29] supplemented with spectinomycin and
erythromycin (for trxB-lacZ) or spectinomycin and chloramphen-
icol (for srfA-lacZ). The overnight cultures were used to inoculate
the same liquid medium at a starting optical density of 600 nm
(OD600) of 0.02. When the OD600 of the cultures reached 0.4 to
0.5, the cultures were divided into two flasks and 1 mM IPTG was
added to one of the flasks. Samples were taken at 0.5- to 1-hr
intervals to assay b-galactosidase activity, which was expressed as
Miller units [30].
Western Blot Analysis
The strains ORB6894 (Spx
DD), ORB6895 (Spx
DD-R60E),
ORB6896 (Spx
DD-K62E), and ORB6897 (Spx
DD-K66E) were
cultured in DS liquid medium supplemented with spectinomycin
and erythromycin as described above. Each culture was divided
into two tubes at an OD600 of 0.4 to 0.5, and 1 mM IPTG was
added to one of the tubes. Two milliliter samples were harvested
after a 1.5-hr incubation and resuspended with 0.5 ml of 20 mM
potassium phosphate buffer pH 7.5, 15 mM MgCl2, 20% sucrose.
Lysozyme (1 mg/ml) was added and the suspension was incubated
by gently shaking at 37uC for 30 min. The protoplasts were
collected by centrifugation at 7,000 x g for 5 min and washed once
with the same buffer. The precipitated protoplasts were lysed by
resuspending with 0.5 ml of lysis buffer (30 mM Tris-HCl,
pH 8.0, 1 mM EDTA) to obtain crude extract. Protein concen-
trations in the crude extract were determined using BioRad
protein assay solution, and 15 mg of total protein was applied to an
Spx-Activated Transcription
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Strain or plasmid Relevant genotype or characteristics
B. subtilis strains
JH642 parental strain James Hoch
ORB3834 Dspx::neo [31]
ORB4028 Dspx::neo his10-rpoC [11]
ORB4055 spx
G52R [31]
ORB4566 Dspx::neo thrC::trxB(2510 to +190)-lacZ [10]
ORB6129 amyE::Pspankhy-spx
DD srfA-lacZ [20]
ORB6894 Dspx::neo thrC::trxB(2510 to +190)-lacZ amyE::Pspankhy-spx
DD This study
ORB6895 Dspx::neo thrC::trxB(2510 to +190)-lacZ amyE::Pspankhy-spx
DD-R60E This study
ORB6896 Dspx::neo thrC::trxB(2510 to +190)-lacZ amyE::Pspankhy-spx
DD-K62E This study
ORB6897 Dspx::neo thrC::trxB(2510 to +190)-lacZ amyE::Pspankhy-spx
DD-K66E This study
ORB6930 amyE::Pspankhy-spx
DD-R60E This study
ORB6931 amyE::Pspankhy-spx
DD-K62E This study
ORB6932 amyE::Pspankhy-spx
DD-K66E This study
ORB6934 amyE::Pspankhy-spx
DD-R60E srfA-lacZ This study
ORB6935 amyE::Pspankhy-spx
DD-K62E srfA-lacZ This study
ORB6936 amyE::Pspankhy-spx
DD-K66E srfA-lacZ This study
ORB7271 Dspx::neo thrC::trxB(G-44C)-lacZ amyE::Pspankhy-spx
DD This study
ORB7272 Dspx::neo thrC::trxB(G-44A)-lacZ amyE::Pspankhy-spx
DD This study
ORB7273 Dspx::neo thrC::trxB(G-33A)-lacZ amyE::Pspankhy-spx
DD This study
ORB7274 Dspx::neo thrC::trxB(G-31A)-lacZ amyE::Pspankhy-spx
DD This study
ORB7275 Dspx::neo thrC::trxB(G-44T)-lacZ amyE::Pspankhy-spx
DD This study
ORB7276 Dspx::neo thrC::trxB-lacZ amyE::Pspankhy-spx
DD This study
ORB7282 Dspx::neo thrC::trxB-lacZ amyE::Pspankhy-spx
DD-R60E This study
ORB7316 Dspx::neo thrC::trxB-lacZ amyE::Pspankhy-spx
DD-C10A This study
ORB7337 Dspx::neo thrC::trxB-lacZ amyE::Pspankhy-spx
DD-G52R This study
ORB7322 Dspx::neo thrC::trxB(C-32A)-lacZ amyE::Pspankhy-spx
DD This study
ORB7342 Dspx::neo thrC::trxB(A-34T)-lacZ amyE::Pspankhy-spx
DD This study
ORB7343 Dspx::neo thrC::trxB(A-34T)-lacZ amyE::Pspankhy-spx
DD-R60E This study
ORB7347 Dspx::neo thrC::trxB(A-34T)-lacZ amyE::Pspankhy-spx
DD-C10A This study
ORB7348 Dspx::neo thrC::trxB(A-34T)-lacZ amyE::Pspankhy-spx
DD-G52R This study
ORB7349 Dspx::neo thrC::trxB(C-32T)-lacZ amyE::Pspankhy-spx
DD This study
ORB7356 Dspx::neo thrC::trxB(G-31C)-lacZ amyE::Pspankhy-spx
DD This study
ORB7368 Dspx::neo thrC::trxB(A-45T)-lacZ amyE::Pspankhy-spx
DD This study
ORB7375 Dspx::neo thrC::trxB(A-42T)-lacZ amyE::Pspankhy-spx
DD This study
ORB7426 Dspx::neo thrC::trxB(G-31T)-lacZ amyE::Pspankhy-spx
DD This study
ORB7427 Dspx::neo thrC::trxB(A-42G)-lacZ amyE::Pspankhy-spx
DD This study
ORB7488 Dspx::neo thrC::trxB(C-43G)-lacZ amyE::Pspankhy-spx
DD This study
ORB7491 Dspx::neo thrC::trxB(C-43T)-lacZ amyE::Pspankhy-spx
DD This study
ORB7540 Dspx::neo thrC::trxB(A-34G)-lacZ amyE::Pspankhy-spx
DD This study
ORB7541 Dspx::neo thrC::trxB(A-34C)-lacZ amyE::Pspankhy-spx
DD This study
ORB7592 Dspx::neo thrC::trxB(A-37C)-lacZ amyE::Pspankhy-spx
DD This study
ORB7593 Dspx::neo thrC::trxB(A-39C)-lacZ amyE::Pspankhy-spx
DD This study
ORB7594 Dspx::neo thrC::trxB(C-43A)-lacZ amyE::Pspankhy-spx
DD This study
ORB7595 Dspx::neo thrC::trxB(T-47G)-lacZ amyE::Pspankhy-spx
DD This study
ORB7596 Dspx::neo thrC::trxB(G-49T)-lacZ amyE::Pspankhy-spx
DD This study
Plasmid
pCSZ28 pDG793 with trxB(G-31T)-lacZ This study
pCSZ29 pDG793 with trxB(A-42G)-lacZ This study
pDG793 thrC integration vector with promoter-less lacZ [28]
Spx-Activated Transcription
PLoS ONE | www.plosone.org 4 January 2010 | Volume 5 | Issue 1 | e8664SDS-polyacrylamide (15%) gel. The Western blot experiment was
done as previously described using an anti-Spx antibody [31].
Protein Purification
RNAP was purified from ORB4028 (spx::neo his10-rpoC)a s
previously described using a Ni-NTA affinity column, a heparin
agarose, and a Bio-Rad High Q column [11,32,33]. The self-
cleavable intein system (New England Biolabs) was used for
overproductionandpurificationofaCTD and Spx.aCTD (residues
225–314) was overproduced in Escherichia coli BL21/pLysS carrying
pSN37[8]andpurified usinga chitincolumnandaBioRadHigh Q
column. s
A was overproduced using pSN64 in E. coli ER2566 (New
England Biolabs) and purified using a chitin column and a High Q
column as previously described [34]. The wild-type Spx protein was
overproduced from pMMN470 [31] in ER2566 and purified using
a chitin column and a BioRad High S column. To overproduce the
Spx
R60E protein, pMMN712 was constructed as follows. The
fragment, amplified by PCR using oligonucleotides oMMN01-135
and oMMN01-137 together with pMMN683 as template, was
digested with NcoI and SmaI and then cloned into pTYB4 (New
England Biolabs) digested withthe same enzymes. ER2566 carrying
pSN21 and pMMN712 were used to overproduce the Spx
G52R [8]
and Spx
R60E mutant proteins, respectively, and the proteins were
purified similarly to the wild-type Spx.
Strain or plasmid Relevant genotype or characteristics
pDYR9 pDG793 with trxB-lacZ [11]
pDYR24 pDG793 with trxB(A-37C)-lacZ [11]
pDYR25 pDG793 with trxB(A-39C)-lacZ [11]
pDYR26 pDG793 with trxB(C-43A)-lacZ [11]
pDYR27 pDG793 with trxB(G-44T)-lacZ [11]
pDYR28 pDG793 with trxB(T-47G)-lacZ [11]
pDYR29 pDG793 with trxB(G-49T)-lacZ [11]
pDR111 amyE integration vector with Pspankhy promoter [26]
pMMN92 SPb carrying srfA-lacZ [18]
pMMN470 pTYB4 with spx [31]
pMMN683 pDR111 with spx
DD-R60E This study
pMMN684 pDR111 with spx
DD-k62E This study
pMMN685 pDR111 with spx
DD-K66E This study
pMMN738 pTYB4 with spx
R60E This study
pMMN745 pDG793 with trxB(G-44C)-lacZ This study
pMMN746 pDG793 with trxB(G-44A)-lacZ This study
pMMN747 pDG793 with trxB(G-33A)-lacZ This study
pMMN748 pDG793 with trxB(G-31A)-lacZ This study
pMMN752 pDG793 with trxB(C-32A)-lacZ This study
pMMN753 pUC19 with spx
DD-G52R This study
pMMN754 pDR111 with spx
DD-G52R This study
pMMN755 pDG793 with trxB(A-34T)-lacZ This study
pMMN756 pDG793 with trxB(C-32T)-lacZ This study
pMMN757 pDG793 with trxB(G-31C)-lacZ This study
pMMN758 pDG793 with trxB(A-45T)-lacZ This study
pMMN759 pDG793 with trxB(A-42T)-lacZ This study
pMMN763 pDG793 with trxB(C-43G)-lacZ This study
pMMN764 pDG793 with trxB(C-43T)-lacZ This study
pMMN775 pDG793 with trxB(A-34G)-lacZ This study
pMMN776 pDG793 with trxB(A-34C)-lacZ This study
pSN21 pTYB4 with spx
G52R [8]
pSN37 pTYB2 with rpoA-CTD [8]
pSN56 pDR111 with with spx
DD [2]
pSN64 pTYB4 with sigA [34]
pTYB4 protein expression vector with intein tag New England Biolabs
pUC19 cloning vector
pZY14 pDR111 with spx
DD-C10A [17]
Unless otherwise noted, trxB-lacZ contains a region between -115 and +47 of the trxB promoter.
doi:10.1371/journal.pone.0008664.t002
Table 2. Cont.
Spx-Activated Transcription
PLoS ONE | www.plosone.org 5 January 2010 | Volume 5 | Issue 1 | e8664In Vitro Transcription
A linear trxB template was generated by PCR with oligonucle-
otides oDY07-32 and oDY07-52. The template is expected to
produce a 66-base transcript. One nM of the template and 25 nM
of RNAP together with 25 nM s
A were incubated without or with
7.5 nM Spx protein in 62.3 ml of 10 mM Tris-HCl pH 8.0,
50 mM NaCl, 5 mM MgCl2, and 50 mg/ml BSA. After 10-min
incubation at 37uC, 7.7 ml of nucleotide mixture (700 mM ATP,
Table 3. Oligonucleotides used in this study.
Oligonucleotide Sequence Purpose
oMMN01-135 AGAGGAGTGAAGATCCATGGTTACACTATAC spx forward
oMMN01-137 TAACTCCCGGGGTTTGCCAAACGCTGTGCTT spx reverse
oMMN07-351 GAAATCATCTCAACCGAGTCAAAAGTATTCCAA spx R60E forward
oMMN07-352 TTGGAATACTTTTGACTCGGTTGAGATGATTTC spx R60E reverse
oMMN07-353 ATCTCAACCCGTTCAGAAGTATTCCAAAAACTG spx K62E forward
oMMN07-354 CAGTTTTTGGAATACTTCTGAACGGGTTGAGAT spx K62E reverse
oMMN07-355 TCAAAAGTATTCCAAGAACTGAATGTGAACGTT spx K66E forward
oMMN07-356 AACGTTCACATTCAGTTCTTGGAATACTTTTGA spx K66E reverse
oMMN08-405 ATCGTGTTGAACAAAAAAATAGCGTATC trxB G-44A forward
oMMN08-406 GATACGCTATTTTTTTGTTCAACACGAT trxB G-44A reverse
oMMN08-407 ATCGTGTTGACCAAAAAAATAGCGTATC trxB G-44C forward
oMMN08-408 GATACGCTATTTTTTTGGTCAACACGAT trxB G-44C reverse
oMMN08-409 GAGCAAAAAAATAACGTATCACCATGAGA trxB G-33A forward
oMMN08-410 TCTCATGGTGATACGTTATTTTTTTGCTC trxB G-33A reverse
oMMN08-411 GAGCAAAAAAATAGCATATCACCATGAGA trxB G-31A forward
oMMN08-412 TCTCATGGTGATATGCTATTTTTTTGCTC trxB G-31A reverse
oMMN08-413 GAGCAAAAAAATAGAGTATCACCATGAGA trxB C-32A forward
oMMN08-414 TCTCATGGTGATACTCTATTTTTTTGCTC trxB C-32A reverse
oMMN08-415 GAGCAAAAAAATTGCGTATCACCATGAGA trxB A-34T forward
oMMN08-416 TCTCATGGTGATACGCAATTTTTTTGCTC trxB A-34T reverse
oMMN08-417 GAGCAAAAAAATAGTGTATCACCATGAGA trxB C-32T forward
oMMN08-418 TCTCATGGTGATACACTATTTTTTTGCTC trxB C-32T reverse
oMMN08-419 GAGCAAAAAAATAGCCTATCACCATGAGA trxB G-31C forward
oMMN08-420 TCTCATGGTGATAGGCTATTTTTTTGCTC trxB G-31C reverse
oMMN08-421 TTTAATCGTGTTGTGCAAAAAAATAGCG trxB A-45T forward
oMMN08-422 CGCTATTTTTTTGCACAACACGATTAAA trxB A-45T reverse
oMMN08-423 TAATCGTGTTGAGCTAAAAAATAGCGTA trxB A-42T forward
oMMN08-424 TACGCTATTTTTTAGCTCAACACGATTA trxB A-42T reverse
oMMN08-436 GAGCAAAAAAATAGCTTATCACCATGAGA trxB G-31T forward
oMMN08-437 TCTCATGGTGATAAGCTATTTTTTTGCTC trxB G-31T reverse
oMMN08-438 TAATCGTGTTGAGCGAAAAAATAGCGTA trxB A-42G forward
oMMN08-439 TACGCATTTTTTCGCTCAACACGATTA trxB A-42G reverse
oMMN08-440 AATCGTGTTGAGGAAAAAAATAG trxB C-43G forward
oMMN08-441 CTATTTTTTTCCTCAACACGATT trxB C-43G reverse
oMMN08-442 AATCGTGTTGAGTAAAAAAATAG trxB C-43T forward
oMMN08-443 CTATTTTTTTACTCAACACCGATT trxB C-43T reverse
oMMN08-461 GAGCAAAAAAATGGCGTATCACCATGAGA trxB A-34G forward
oMMN08-462 TCTCATGGTGATACGCCATTTTTTTGCTC trxB A-34G reverse
oMMN08-463 GAGCAAAAAAATCGCGTATCACCATGAGA trxB A-34C forward
oMMN08-464 TCTCATGGTGATACGCGATTTTTTTGCTC trxB A-34C reverse
oMMN08-465 TAATCGTGTTGAGCAAAAAAATAGCGTATCACCATG trxB (256 to -21)
oMMN08-466 CATGGTGATACGCTATTTTTTTGCTCAACACGATT trxB (221 to -55)
oMMN08-473 TAATCGTGTTGAACAAAAAAATAACGTATCACCATG trxB G-44A G-33A forward
oMMN08-474 CATGGTGATACGTTATTTTTTTGTTCAACACGATT trxB G-44A G-33A reverse
doi:10.1371/journal.pone.0008664.t003
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32PUTP) was added to
each reaction. After incubation at 37uC for 2, 5, and 10 min, 20 ml
of the reaction was withdrawn to mix with 10 ml of stop solution
(1 M ammonium acetate, 0.1 mg yeast RNA, and 0.03 M EDTA).
The mixture was precipitated with ethanol and resuspended with
5 ml of formamide-dye (0.3% xylene cyanol, 0.3% bromophenol
blue, and 12 mM EDTA dissolved in formamide). The samples
were heated at 90uC for 2 min and were applied onto an 8%
polyacrylamide-urea gel. The gel was dried and autoradiographs
were scanned on a Typhoon Trio scanner (GE Healthcare).
Electrophoretic Mobility Shift Assay (EMSA)
The probe used for EMSA was a fragment extending from 256
to 221 of the trxB promoter region, which was generated by
annealing complementary oligonucleotides. The 36-mer
oMMN08-465 was the template strand and the 35-mer
oMMN08-466 was the non-template strand that lacks A
(complementary to 256T) at its 39-end. The two oligonucleotides
(5 pmoles each) were mixed in 20 ml of 10 mM Tris-HCl pH 7.9,
50 mM NaCl, 10 mM MgCl2 and heated at 90uC for 5 min, then
slowly cooled to room temperature. To radiolabel the non-
template strand, Klenow fragment and 10 mCi of [a-
32P]dATP
(800Ci/mmol) were added to the annealing reaction to fill-in the
39 end. After incubation at room temperature for 15 min,
unincorporated [a-
32P]dATP was removed using a nucleotide
purification kit (Qiagen). The mutant (G-44A G-33A) trxB and
spoVG probes were generated in a similar manner, except using
oligonucleotides oMMN08-473 and oMMN08-474, and
oMMN09-477 and oMMN09-478, respectively.
Five mM of Spx and 5 mMo faCTD (unless otherwise stated)
were incubated at room temperature for 10 min in 20 mlo f
20 mM Tris-HCl pH 7.8, 50 mM NaCl, 5 mM MgCl2, 10%
glycerol. The radiolabeled probe (2,000 cpm/reaction) was added
to the preincubated mixture and further incubated at room
temperature for 15 min. The reaction mixture was applied onto a
pre-run 6% native polyacrylamide gel and run in TGE buffer
(50 mM Tris, 0.38 M glycine, 2 mM EDTA) at 180V. The gel
was dried and scanned on a Typhoon Trio variable mode imager.
Results
The Wild-Type and Spx(C10S) Structure
Formation of the disulfide bond between C10 and C13 is
essential for the positive regulatory role of Spx, but not for its
negative role [10,20,35]. We hypothesized that a conformational
change caused by formation of the disulfide bond could provide a
mechanism for how Spx is involved in the transcriptional
activation of genes such as trxA and trxB. Therefore, the crystal
structure of Spx (C10S), which mimics the reduced form, in
complex with the aCTD was determined to 1.9 A ˚ resolution
(Figure 1A).
The structure of the reduced aCTD-Spx complex is quite
similar to that of the oxidized aCTD-Spx complex [9,36] and an
overlay of 156 corresponding Ca atoms of both complexes,
excluding residues on helix a4 of Spx, results in a root mean
square deviation of 0.6 A. As seen previously the aCTD contains
four core a helices (a1–a4) and a somewhat extended N-terminal
helix designated a19 (Figure 1A). The reduced C10S Spx protein is
a mixed a/b protein with its secondary structural elements
arranged: b1a1b2a2a3(310)a5b3b4a6 (Figure 1A). Thus, Spx
retains most of the secondary structure that is found in oxidized
Spx. Importantly, the aCTD-Spx interface of the reduced
complex is identical to that of the oxidized aCTD-Spx complex
indicating that the biological effects of thiol stress readout by these
proteins are not a consequence of a radically different structure of
this complex.
Interestingly, the loss of the disulfide linkage between residues
C10 and C13 does not result in a significant change in the local
structure (Figure 1B). Although free to rotate from their positions
in the oxidized state, the S10 and C13 side chains do not move
Figure 1. Structure of reduced C10S Spx in complex with aCTD. (A) Spx and aCTD are shown as teal and green ribbons, respectively, and
their secondary structures are labelled. Helix a4, which is observed in oxidized Spx [9] but has unraveled in the reduced form, is colored magenta. The
residues mutated in this study, R60 and K62, are labelled and shown as sticks with carbon atoms colored white and nitrogen atoms either blue or
magenta. Residues S10 and C13 are labelled and shown as sticks with carbon and sulphur atoms colored yellow and the c-oxygen of S10, red. (B)
Close up of the region surrounding helix a4 and residues C10/S10 and C13 after the superposition of the oxidized and reduced aCTD-Spx complex
structures. Reduced Spx is shown as a magenta ribbon and oxidized Spx as a teal ribbon. The C10-C13 disulfide bond is shown in orange sticks and
S10 and C13 from the reduced structure are shown as yellow sticks. In the reduced form residue R92 has moved 2.8 A ˚ away from its position in the
ammonium sulphate-containing oxidized form [9]. The side chain of residue R60 beyond the Cb atom is disordered in the sulphate-containing crystal
form of oxidized Spx, which was used in the superposition visualized here [9].
doi:10.1371/journal.pone.0008664.g001
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Indeed the S10 Oc side chain engages in hydrogen bonds to the
backbone amide (NH) group of C13 and Oc atom of residue S12.
The C13 Sc sulfhydryl group hydrogen bonds to hydroxyl side
chain of residue S10 and makes van der Waals contacts with
residues R92 and P93. Also, due to two alternative backbone
conformations around residues S7 and P8, the S7 backbone
carbonyl oxygen can engage in a weak hydrogen bond to the C13
SHc group.
One significant conformational difference is found between
oxidized and reduced Spx, however, whereby helix a4 of the
reduced mutant Spx structure (residues S61 to N68 in oxidized
Spx) unfolds and rotates (Figure 1). As a consequence of the
unravelling of helix a4, several basic residues are repositioned.
Specifically, the side chain of residues K62, which points into the
solvent in oxidized Spx and is disordered, turns inward and now
makes hydrogen bonds to the carbonyl oxygen (CO) atom of
residue G88 and the Oc atom of residue Ser58. Residue K66,
which is also solvent exposed in oxidized Spx, is now pointing into
the core of the protein. Hence, the exposed electropositive surface
of a4 is decreased significantly in reduced Spx. Other helix a4-
related conformational changes include the repositioning of
residue R60, whereby its Ca carbon has moved 1.3 A ˚ from its
oxidized position. The side chain of the R60 residue, which points
directly into the solvent and is disordered in one crystal structure
of oxidized Spx but not in the second [36], has moved 5.8 A ˚ (Cf–
Cf) from its position in the oxidized protein and has shifted
towards R92 by 1.3 A ˚ (Figure 1B). The potential importance of
this altered location is tied to residue R92. In reduced mutant Spx,
the side chain of residue R92 has rotated outward by ,2.8 A ˚ from
its location in oxidized Spx. In the oxidized protein, the
guanidinium side chain is engaged in an electrostatic interaction
with a bound sulfate ion [9]. In the reduced protein, the R92 side
chain rotates inward and makes hydrogen bonds to the peptide
backbone carbonyl oxygen atoms of residues G88 and L90
(Figure 1B). This location of the R92 side chain of reduced Spx is
very similar to its location in oxidized Spx crystallized from
solutions that do not contain sulfate or phosphate anions [36].
Perhaps, the R92-bound sulfate ion described in the first reported
oxidized Spx structure is a surrogate for one of the phosphate
groups of (aCTD-Spx)-bound DNA. If so, this also places the
solvent exposed guanidinium group of residue R60 near the DNA
phosphate backbone and suggests its possible role in DNA binding,
either to the backbone or to a guanine. Thus, loss of the Spx C10-
C13 disulfide bond results only in small conformational changes
that are confined primarily to helix a4. However, the resulting
helix-to-coil transition repositions the side chains of several basic
residues that could have functional consequences with respect to
DNA binding.
Residues in or Near Helix a4 of Spx Are Important for trxB
Activation but Not for srfA Repression by ComA Activator
Interference
To determine whether the structural change in helix a4i s
crucial for the function of Spx in transcription activation, we next
introduced single amino acid substitutions around the helix a4
region. Interestingly, there are some basic residues adjacent to and
within the helix, namely, R60, K62, and K66. Since basic amino
acids are known to interact with DNA through sequence
recognition and charge neutralization [37], we decided to
substitute each residue with glutamate and to examine the effect
of these substitutions on Spx activity. Because under nonstress
conditions Spx is degraded by ClpXP protease, we expressed the
ClpXP-resistant forms (Spx
DD) of the wild-type and mutant
proteins from an IPTG-inducible promoter, as previously
described [2] so that we could examine the mutational effect on
trxB transcription under nonstress conditions. Western blot
analysis showed that the three mutant Spx proteins were produced
only in the presence of IPTG at a level similar to the wild-type
protein (Figure 2). trxB-lacZ expression in cells producing Spx
K66E
was equal to or greater than that observed in cells producing the
wild-type Spx (Figure 3A). In contrast, the K62E mutation
reduced transcription and the R60E mutation nearly abolished
transcription, indicating that R60, and to a lesser extent K62, are
important for transcriptional activation of trxB.
Although Spx
R60E and Spx
K62E are produced at a level similar
to the wild-type Spx in B. subtilis cells, we could not completely
eliminate the possibility that the mutant proteins were misfolded,
and thus, inactive. As described earlier, Spx plays both a positive
and negative role in transcription regulation. To examine whether
the mutant proteins retain the ability to exert negative transcrip-
tional control, we determined the effect of the mutations on
ComA-dependent srfA transcription. As shown in Figure 3B, srfA
Figure3. Effect ofamino acid substitutions within and nearhelix
a4 of Spx on the transcription of trxB (A) and srfA (B).S t r a i n s
carryingtrxB-lacZ (A) or srfA-lacZ (B) were grown in DSmedium. Whenthe
OD600 was 0.4 to 0.5, each culture was divided into two flasks, and 1 mM
IPTG was added to one flask to induce Spx
DD. Samples were taken at time
intervals and b-galactosidase activities were measured. (A) Symbols:
squares, ORB6894 with Spx
DD; circles, ORB6895 with Spx
DD-R60E;t r i a n g l e s ,
ORB6896 with Spx
DD-K62E;d i a m o n d s ,O R B6 8 9 7w i t hS p x
DD-K66E.( B )
Symbols: squares, ORB6129 with Spx
DD; circles, ORB6934 with Spx
DD-R60E;
triangles, ORB6935 with Spx
DD-K62E; diamonds, ORB6936 with Spx
DD-K66E.
Open symbols represent cells cultured without IPTG and closed symbols
represent cells cultured with IPTG.
doi:10.1371/journal.pone.0008664.g003
Figure 2. Production of the wild-type and mutant Spx in B.
subtilis. B. subtilis cells expressing the wild-type and the mutant Spx
DD
(the C-terminal two amino acids are substituted with aspartate residues,
which renders the Spx protein insensitive to ClpXP protease) were
grown in DS medium in the absence (lanes 1, 3, 5, and 7) and the
presence of IPTG (lanes 2, 4, 6, and 8) as described in Materials and
Methods. The lysate was prepared by the protoplast lysis method as
described and 15 mg of total protein was resolved by SDS-polyacryl-
amide gel electrophoresis. Western blot analysis was carried out to
detect Spx as shown previously. Lanes: M, molecular weight marker; 1
and 2, ORB6894 (Spx
DD), ORB6895 (Spx
DD-R60E), ORB6896 (Spx
DD-K62E),
and ORB6897 (Spx
DD-K66E).
doi:10.1371/journal.pone.0008664.g002
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wild-type Spx protein and in all of the strains that produced the
mutant proteins. These results clearly demonstrated that R60 and
K62 of Spx play pivotal roles in positive control but are
dispensable for its negative role in transcription.
Identification of trxB Sequences Required for
Spx-Dependent Transcription Activation
One possible hypothesis for why R60 (and to a lesser extent
K62) is required for trxB transcription and not for inhibition of
activator-dependent srfA transcription is that R60 is involved in the
interaction of Spx with the trxB promoter DNA for establishing the
transcription initiation complex. Although Spx itself did not bind
trxB DNA [10], this result does not necessarily eliminate the
possibility that Spx, by interacting with aCTD, can contribute part
of a DNA-binding surface. The intracellular disulfide bond
formation might facilitate the recognition and/or binding of the
side-chain of R60 with a specific nucleotide in the trxB promoter
region, as suggested above. Alternatively, Spx residue R60 might
function indirectly in DNA sequence recognition by changing the
conformation of aCTD so that it recognizes specific sequences
associated with Spx-activated promoters. We think that this is
unlikely as explained in the Discussion.
Our previous work demonstrated that the trxB promoter region
between 250 and 236 is required for Spx-dependent transcrip-
tion activation and that the nucleotides at positions 243 and 244
are essential for transcription [10,11]. The identified region
corresponds well with the sequence protected from DNase I
digestion in the presence of the wild-type Spx-RNAP complex
[10]. The DNase I footprinting analyses also identified a
hypersensitive site between 234 and 235 of the trxB template
strand in the presence of Spx-RNAP [10]. Interestingly, Spx-
RNAP generated a hypersensitive site at a similar position
(between 235 and 236) of trxA, a gene that is also activated
directly by Spx. Furthermore, the nucleotide sequences (AAAA-
TAGCGT) of the trxA (240 to 231) and trxB (239 to 230)
regions that include the hypersensitive site are identical. These
observations prompted us to carry out further mutational analyses
of the 239 to 230 region of trxB.
As in the previous study [11], we used the trxB promoter
carrying 2115 to +47 for base substitution experiments, except
that we expressed the IPTG-inducible Spx
DD in the strain lacking
the native spx gene. The results showed that three segments of trxB
are important for Spx-dependent transcription activation
(Figure 4). The first segment is the AGCA sequence positioned
from 245 to 242. Our previous study showed that the G at 244
and C at 243 are indispensable for transcription [10,11]. The
second segment is a poly-A stretch between 241 and 236. In our
previous study, base substitution of two of the A residues showed a
moderate effect on trxB transcription in the spx
+ background [11],
and here, these substitutions showed more adverse effects in cells
lacking the native spx gene (Figure 4). It has been known that
aCTD binds to AT-rich sequences; for example, the sequence
AAAAAARNR at positions 246 to 238 of the E. coli rrnB
promoter P1 serves as the proximal aCTD-binding site [38]. We,
therefore, propose that the sequence between 241 and 235 is a
site for aCTD interaction. The last segment important for trxB
transcriptional control by Spx is the GC sequence positioned at
233 and 232. Our previous work showed that Spx-dependent
activation of a trxB/srfA hybrid promoter transcription was
enhanced further by extending the trxB control region to 231
including the GC at 232/33 [11]. The dinucleotide resides in the
center of the AGCG sequence that is similar to the upstream
essential AGCA (245 to 242) sequence. The G residue in the
second position is the most critical among the tetranucleotides
AGCA and AGCG. Because the two tetranucleotides are similar,
with the exception that the most 39-end of the upstream sequence
is A (242) the corresponding position of the downstream sequence
is G (231), we examined the effect of base substitution of the G at
position 231. We found that substitution of G with either C or T
had no significant effect, whereas the substitution with A led to a
more than two-fold increase in trxB expression. One interpretation
of this result is that the Spx/aCTD complex binds to trxB and that
Spx contacts the AGCA sequence and aCTD contacts the
downstream A-rich sequence. If this is true, then the question is
which protein, if any, binds to the downstream AGCG sequence.
The previous crosslinking study did not show contact of any
protein to the 235 region [11], and was, therefore, inconclusive.
One could envision three alternative scenarios for a protein/235
Figure 4. Effect of base substitutions of the trxB promoter on trxB expression. Single base pair substitutions were generated in the trxB
promoter (2115 to +47). The mutated promoters fused to lacZ were introduced in spx mutant strains expressing spx
DD from the IPTG-inducible
Pspank-hy promoter. Expression of trxB-lacZ was determined in at least two independent isolates as described in Fig. 3. The effect of each base
substitution is shown as a percentage of the peak trxB transcribed from the wild-type promoter, which was used as a control in each experiment. The
peak expression was generally seen around 1.5 hr after the addition of IPTG.
doi:10.1371/journal.pone.0008664.g004
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A binds to this sequence, which
is facilitated by the interaction between s
A and aCTD bound to
the site upstream of 235. Another scenario is that the downstream
AGCG sequence is a site where Spx binds. A third possibility is
that the second aCTD, having undergone a conformational
change upon contact with oxidized Spx, now recognizes the
sequence centered at 233. For the reasons presented in the
Discussion, this possibility seems unlikely. The issue of 233
element recognition will be discussed below (see Discussion).
Activation-Defective Spx Mutants Other Than G52R Are
Able to Activate a Mutant trxB Promoter Bearing an
A-34T Mutation
The mutational analysis showed that the A-34T substitution
resulted in highly elevated trxB transcription, which remained
largely dependent on Spx because IPTG was still required for
promoter activity (Figure 4). We examined expression of trxB(A-
34T)-lacZ in cells expressing spx
R60E, spx
C10A, and spx
G52R mutants,
as well as the wild-type spx. As shown in Figure 5A, transcription
from the wild-type trxB promoter was severely reduced in cells
producing each mutant Spx
DD protein as compared with those
producing wild-type Spx
DD. In contrast, the R60E and C10A Spx
mutants were able to activate the A-34T promoter, although the
activity of the mutant proteins was approximately 50% of the
activity of the wild-type protein (Figure 5B). No expression was
observed in the absence of IPTG, indicating that the observed
expression is dependent on mutant Spx protein. Unlike the two
Spx activation mutants, the Spx
G52R mutant protein was
completely impaired in activating transcription from the mutant
promoter. This result indicates that the G52 residue, and hence,
the Spx-aCTD interaction is absolutely required for Spx-activated
trxB transcription, but the requirement of residues R60 and C10 is
conditional, given that the spx mutations R60E and C10A are
partially suppressed by the A-34T mutation in the trxB promoter.
Spx
R60E Activates trxB(A-34T) Transcription In Vitro
The in vivo results described above showed that Spx
R60E and
Spx
C10A are unable to activate transcription from the wild-type
trxB promoter, but are able to significantly activate trxB(A-34T)
transcription. We next carried out in vitro run-off transcription
experiments to determine whether the effect of the A-34T
substitution can be solely attributed to interactions involving the
trxB(A-34T) promoter, Spx, and RNAP. Figure 6 shows that the
basal level of trxB transcription was markedly elevated by adding
wild-type Spx, but only a slight increase in the transcript was
detected in reactions containing Spx
R60E. The trxB(A-34T)
transcript accumulated slightly more than the wild-type trxB
transcript at a longer reaction time (10 min) in the absence of Spx,
and the transcript levels were increased further when the wild-type
Spx was present. Unlike the wild-type transcript levels, those of the
mutant trxB were markedly elevated by Spx
R60E. We repeated
these experiments almost ten times and in some experiments we
did not see any difference between the wild-type and the mutant
trxB transcript levels activated by the wild-type Spx as shown in
Figure 6; however, in other experiments, we observed that the
mutant trxB transcript level was significantly higher than the wild-
type transcript level. Although we do not understand the
variability in the in vitro transcription results, Spx
R60E reproduc-
ibly activated transcription from the trxB(A-34T) promoter to a
higher level than from the wild-type promoter. Based on the in vitro
transcription assays, we conclude that the adverse effect of the
R60E mutation on trxB transcription is likely caused by either a
weaker interaction of the mutant Spx with the trxB promoter,
RNAP, or both.
The Spx-aCTD Complex Binds the trxB Regulatory Region
The mutational studies of the trxB promoter uncovered a region
of trxB required for Spx-dependent activation [10,11], and this
putative cis-acting component of Spx control was further
investigated. Given that the A-rich sequence and the flanking
AGCA and AGCG sequences are conserved between the trxA and
trxB promoters and that the upstream AGCA sequence is also
present in other Spx-controlled genes (see Discussion), one could
envisage that the AGCA sequence (and possibly AGCG in trxA
and trxB) is the site where Spx binds. To test this possibility, we
next carried out EMSA analysis using a DNA fragment carrying
the trxB promoter (256 to 221). This fragment covers the putative
Spx- and aCTD-binding sites, but lacks the 210 region. We first
examined whether either aCTD or Spx alone binds DNA. aCTD
at 5 mM bound DNA, but Spx at the same concentration did not
(Figure 7A, lanes 2 and 6). Although Spx itself was unable to bind
DNA at the concentration tested, Spx addition resulted in a
supershifted complex with promoter DNA and aCTD, indicating
that a DNA-aCTD-Spx ternary complex was formed (Figure 7A,
lane 3). In contrast, the supershifted band was not detected with
Figure 6. In vitro transcription from the wild-type and trxB(A-
34T) promoters in the absence and presence of the wild-type
and R60E Spx. Either the wild-type or A-34T trxB template (1 nM) was
incubated with 25 nM RNAP together with 25 nM s
A in the presence of
7.5 nM Spx. The arrow shows the 66-base trxB transcript.
doi:10.1371/journal.pone.0008664.g006
Figure 5. Effect of the A-34T substitution on trxB transcription
activated by the wild-type and mutant Spx. Strains carrying trxB-
lacZ fusions were grown in DS medium. When the OD600 was 0.4 to 0.5,
each culture was divided into two flasks, and 1 mM IPTG was added to
one flask. Samples were taken at time intervals and b-galactosidase
activities were measured. (A) Expression of the wild-type trxB-
lacZ. Symbols: squares, ORB7276 with Spx
DD; triangles, ORB7282 with
Spx
DD-R60E; diamonds, ORB7316 with Spx
DD-C10A; circles, ORB7337 with
Spx
DD-G52R. (B) Expression of trxB(A-34T)-lacZ.S y m b o l s :s q u a r e s ,
ORB7342 with Spx
DD; triangles, ORB7343 with Spx
DD-R60E; diamonds,
ORB7347 with Spx
DD-C10A; circles, ORB7348 with Spx
DD-G52R. Open
symbols represent cells cultured without IPTG and closed symbols
represent cells cultured with IPTG.
doi:10.1371/journal.pone.0008664.g005
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G52R (Figure 7A, lane 5), arguing that formation of the ternary
complex is dependent on the interaction of Spx and aCTD. The
effect of R60E Spx on the DNA-aCTD complex was completely
different from that of either the wild-type Spx or Spx
G52R; Spx
R60E
prevented DNA and aCTD from forming a complex (Figure 7A,
lane 4). Furthermore, addition of Spx
G52R did not affect the
ternary complex formed by the wild-type Spx (Figure 7A, lane 15).
In contrast, addition of Spx
R60E negatively affected the DNA-
aCTD-wild-type Spx complex (Figure 7A, lane 13), and
completely abolished the DNA-aCTD binary complex
(Figure 7A, lane 14) when it was included in the binding reaction
with the G52R protein (compare with Figure 7A, lane 11, a
reaction containing the G52R mutant protein alone with aCTD).
The ternary complex, but not the binary complex, was only
formed in the absence of DTT (Figure 7B), which is in good
agreement with the hypothesis that the oxidized form of Spx is
required for DNA binding.
We next examined whether the trxB mutations that affect Spx-
dependent activation had lower binding affinities for the Spx-
aCTD complex. The trxB promoter fragment bearing the G-44A
and G-33A mutations was used for a probe in EMSA to compare
the binding affinity for aCTD and Spx-aCTD (Figure 8). When
Spx was added in equal concentrations in reactions containing
trxB(wt)-aCTD or trxB(G-44A G-33A)-aCTD, the ternary com-
plex was more abundant when the wild-type promoter was present
than when the mutant promoter was present (Figure 8, lanes 4 and
5, and 8 and 9). Even in the reaction in which more aCTD bound
to the mutant promoter than the wild-type promoter, Spx was
unable to supershift the mutant promoter complex as efficiently as
the wild-type promoter complex (Figure 8, lanes 11 to 16). A
mutant trxB-lacZ fusion bearing the two nucleotide substitutions
produced 0.7 units of b-galactosidase activity (data not shown).
These results support the assumption that G-44A (and G-33A) is
important for the binding of Spx to the trxB promoter. We carried
out a similar experiment with the trxB promoter carrying either the
G-44A or G-33A mutation to determine which residue is critical
for Spx binding; however, the trxB promoter carrying the single
mutation did not show a significant difference from the wild-type
promoter in EMSA analysis (data not shown).
We examined whether the DNA-aCTD-Spx complex is specific
to promoters of Spx-activated genes by using the spoVG promoter
in a similar EMSA analysis. The spoVG promoter has an AT-rich
upstream sequence that was shown to have properties of an UP
element, and was required for transcription [39,40]. Spx did not
activate transcription of spoVG; conversely, the transcription was
shown to be inhibited by overproduction of Spx through an as yet
undiscovered mechanism [41,42]. The spoVG promoter exhibited a
much higher affinity for aCTD than the trxB promoter, yet
addition of Spx did not result in a supershifted DNA-aCTD
complex even when an excess of Spx over aCTD was added
(Figure 9A). In addition, when the cold spoVG fragment was added,
it was able to disrupt both aCTD- and aCTD-Spx-binding to the
trxB promoter (Figure 9B). These results suggest that spoVG has a
higher affinity for free aCTD than aCTD complexed with Spx,
and once aCTD binds the spoVG promoter, Spx is unable to
establish an interaction with aCTD.
Discussion
This study was aimed at elucidating how the oxidized form of
Spx activates trxB transcription. The questions to be answered
were: 1) how disulfide-bond formation at the redox CXXC center
of Spx affects its activity as a transcriptional activator; 2) whether
oxidized Spx in the Spx-aCTD complex binds to the trxB
promoter region and enhances the binding of aCTD or other
Figure 7. Interaction of aCTD and Spx variants with the regulatory region of the trxB promoter. The trxB probe (256 to 221) was
generated by annealing of oligonucleotides followed by labeling of the 39-end of the template strand using Klenow fragment and [
32P]dATP. Bands
corresponding to the trxB/aCTD and trxB/Spx/aCTD complexes are marked with arrows. (A) EMSA analysis of aCTD and Spx binding to the trxB probe
in reactions containing Spx variant or mixtures of mutant Spx proteins or mutant with the wild-type Spx (each at 5 mM). Abbreviations: W, wild-type
Spx; G, Spx
G52R; R, Spx
R60E. (B) Redox-sensitive interaction was examined in the presence of DTT.
doi:10.1371/journal.pone.0008664.g007
Figure 8. Effect of trxB base substitutions on interaction with
aCTD and Spx. The wild-type (W) and the trxB (G-44A/G-33A) mutant
(M) probes were incubated with different concentrations of aCTD and
Spx as described in Figure 7.
doi:10.1371/journal.pone.0008664.g008
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consensus Spx-binding site in trxB and other Spx-activated
promoters. A comparison of the crystal structures of the oxidized
(wild-type) and reduced (C10S) forms of Spx revealed that in the
reduced form helix a4 partially unfolds and rotates, suggesting that
helix a4 could be important for the positive role of Spx in
transcription. Consistent with this assumption, mutations of Spx
residues R60 and K62, which are adjacent to and within helix a4,
respectively, reduced Spx-dependent trxB transcription but did not
show any effect on its repression of ComA-dependent srfA
expression. We found that the R60 and K62 residues are well
conserved among Spx orthologs, whereas residue 66 is a glutamate
instead of lysine in Spx from some Bacillus species such as Bacillus
cereus, Bacillus thuringiensis, Bacillus clausii, Bacillus halodurans, and
Bacillus weihenstephanensis. The observation supports the important
role of residues R60 and K62 in the function of Spx as a
transcriptional activator.
The current mutational analysis of the trxB promoter not only
confirmed the results from our previous work, but also further
defined the cis-sequences required for Spx-dependent activation.
Based on the mutational analyses and the EMSA experiments, we
now propose that the AGCA sequence at 245 to 242 is the site
with which the complex of aCTD with oxidized Spx directly
interacts. This hypothesis is further supported by the following
observations. Our previous microarray analysis [2] identified nfrA,
coding for nitro/flavin reductase [43,44], as one of the genes
activated by Spx. nfrA was also shown to be activated in response
to a number of stress condition, including oxidative stress [43,45]
and the nfrA promoter contains the AGCA sequence at the same
position (245 to 242) as in the trxB promoter. Base substitutions
of the first three nucleotides in this sequence, particularly G and C,
resulted in a substantial reduction in the promoter activity,
indicating the essential role of the AGCA sequence in nfrA
transcription [43]. Our studies further showed that Spx activates
nfrA-lacZ in vivo and the R60E mutation in Spx severely affects
nfrA expression (A. L, and P. Z., unpublished results). In addition,
an in vitro transcription assay showed that Spx directly activates
nfrA transcription (A.L. and P.Z., unpublished results). The results
are in good agreement with the hypothesis that the helix a4 of Spx
functions in the interaction of aCTD/Spx complex with the
AGCA sequence. We feel that it is unlikely that a conformational
change of aCTD caused by Spx is responsible for the recognition
of promoter DNA solely by the a polypeptide, as no uncharac-
teristic change in a conformation is observed when aCTD is
bound to Spx [9,36].
In contrast to the AGCA sequence, the downstream AGCG
sequence at 234 to 231, which is conserved in trxA and trxB,i s
absent in the nfrA promoter; hence, its role in transcriptional
activation is unclear. Interestingly, the substitution of A at 234
with T resulted in a slightly higher basal level of trxB expression
and a five-fold increase in Spx-dependent activation as compared
with transcription from the wild-type promoter (Figures 4 and 5).
Furthermore, trxB transcription from the mutant promoter was
significantly stimulated by Spx
R60E and Spx
C10A (Figures 5 and 6),
whereas the G52 residue was absolutely required for transcription.
The A-34T change leads to a 3/6 match to the consensus 235
hexamer recognized by s
ARNAP [46]. One possible scenario is
that s
A binds to the 235 region of the mutant promoter and the
interaction between Spx and aCTD at the 244 element, as well as
interaction of aCTD with s
A, stabilizes the three proteins at the
mutant promoter, which partially compensates for the defect in
trxB interaction conferred by the R60E substitution. In contrast,
the G52R mutation, by disrupting the interaction of Spx with
aCTD, destabilizes aCTD binding to trxB, resulting in decreased
engagement of s
A with the 235 region. Does this possibility
suggest that s
A also interacts with the 235 region of the wild-type
trxB promoter? Another mutation, C at 232 to A, which results in
a 3/6 match to the consensus 235 hexamer did not increase trxB
transcription, and instead, showed a severe adverse effect,
suggesting that s
A does not bind to the 235 of region the wild-
type promoter and/or that the A-34T mutation increases the
affinity of s
A binding more than C-32A. The A-34T change leads
to the sequence TTGCGT. The TTG in the 235 region seem to
be the most important nucleotides of the 235 hexamer as these
are the most highly conserved [46], which could explain the
opposite phenotypes conferred by the C-32A and A-34T
mutations.
Our previous study [11] showed that s
A crosslinks to trxB at
position 211 but not at 234. Furthermore, Spx did not crosslink
to any nucleotide tested. One possible reason for this negative
result may be the limited positions tested in the crosslinking
experiments. Within the three important regions found in this
work, the nucleotide positions tested for crosslinking were 246
and 234 of trxB and 247, 235, and 230 of trxA. Only 234A of
trxB and 235A of trxA reside within the AGCG sequence. Another
possible reason for the negative result is that the modification of a
nucleotide with azidophenacyl bromide might have interfered with
the binding of either Spx or s
A to DNA. It would be worth
revisiting the nucleotide-specific crosslinking study by focusing on
the AGCA and AGCG sites, as well as the A-rich sequence, and
Figure 9. Interaction of aCTD and Spx with the spoVG promoter carrying AT-rich upstream sequences. (A) The radiolabeled spoVG probe
was generated as described in Figure 7. The spoVG-aCTD complex is marked with an arrow. (B) Competition of the trxB-aCTD and trxB-Spx-aCTD
complexes with spoVG was examined by the addition of a 2- to 50-fold excess of cold spoVG probes.
doi:10.1371/journal.pone.0008664.g009
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Direct interaction between protein and DNA can also be
verified genetically by site-specific suppressor analysis. Earlier
studies of the sigma subunit-DNA interaction [47,48] demonstrat-
ed that mutations of the third G of the 235 hexamer to either A or
C, but not to T, were suppressed by the substitution of Arg588 in
region 4 of s
70 with His. Similarly, the defect caused by
substitution of the fifth C of the 235 hexamer with either T or
G was compensated for by the substitution of Arg584 of s
70 with
Cys or His. We have investigated whether the various single base
substitutions of G at 244, C at 243, G at233, or C at 232, as
well as double mutation of either G at 244/233 or C at 243/
232, were restored by introducing the R60H or R60C mutations
in Spx; however, we could not detect any significant suppressing
effect in any of the mutant combinations (M.M.N. and P.Z.
unpublished results).
The aCTD of RNAP can make specific contact with the UP
element sequence of certain promoters such as those of rRNA
operons [49] and the spoVG gene of B. subtilis (Figure 9). Evidently,
the aCTD in the Spx-aCTD complex engages the trxB promoter
DNA in a manner that is different from its interaction with the UP
element, as Spx is unable to contact aCTD on the spoVG promoter
fragment. Some of the aCTD residues required for UP element
contact might also function in its interaction with Spx, and thus,
may not be available for Spx-aCTD complex formation. The a1
helix of aCTD contains part of the ‘‘261 element’’ that is required
for DNA binding, and this helix also contains the essential Tyr
residue for Spx interaction. Given that part of the a1 helix
interacts with Spx further suggests that only part of the DNA-
binding surface in aCTD might be exposed for DNA recognition,
and that interaction with Spx is required to complete the DNA
binding surface of the aCTD/Spx promoter recognition complex.
We, and others, have successfully cocrystallized aCTD and
oxidized Spx as previously reported [9,36]. The EMSA study
presented here now opens a powerful approach for cocrystalliza-
tion of the aCTD-Spx complex with DNA to study the ternary
interaction.
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